title: Thymidine kinase 1--a prognostic and diagnostic indicator in ALL and AML patients.
authors.forename: K L
authors.initials: KL
authors.lastname: O'Neill
authors.forename: F
authors.initials: F
authors.lastname: Zhang
authors.forename: H
authors.initials: H
authors.lastname: Li
authors.forename: D G
authors.initials: DG
authors.lastname: Fuja
authors.forename: B K
authors.initials: BK
authors.lastname: Murray
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood*; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000097:blood* / Q000175:diagnosis / Q000401:mortality; D008297:Male; D009363:Neoplasm Proteins / Q000097:blood*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood* / Q000175:diagnosis / Q000401:mortality; D011379:Prognosis; D013937:Thymidine Kinase / Q000097:blood*; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D013937:Thymidine Kinase; C092717:thymidine kinase 1